Taux de pénétration des génériques de la buprénorphine haut dosage : principales tendances de 2006 à 2008
Therapie, 67 2 (2012) 129-136
Published online: 2012-08-02
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Novel forms of injectable buprenorphine and French model of opioid use disorder treatment
Maryse Lapeyre-MestreTherapies 75 (5) 393 (2020)
https://doi.org/10.1016/j.therap.2020.09.007
Dispositif pharmacoépidémiologique de surveillance des substances psychoactives : intérêts du programme national OPPIDUM du Réseau français d’addictovigilance
Elisabeth Frauger, Liselotte Pochard, Quentin Boucherie, et al.Therapies 72 (4) 491 (2017)
https://doi.org/10.1016/j.therap.2017.01.010
Caractéristiques des sujets sous traitement de substitution vus en médecine générale d’après l’enquête nationale OPEMA 2013
Gaëtan Gentile, Elisabeth Frauger, Adeline Giocanti, et al.Therapies 71 (3) 307 (2016)
https://doi.org/10.1016/j.therap.2016.02.001
Preference for Brand-Name Buprenorphine is related to Severity of Addiction among Outpatients in Opioid Maintenance Treatment
Philippe Binder, Nassir Messaadi, Marie-Christine Perault-Pochat, et al.Journal of Addictive Diseases 00 (2016)
https://doi.org/10.1080/10550887.2015.1136494
Décès en relation avec l’abus de médicaments et substances (Drames) : focus en région Languedoc-Roussillon
W. Champeau, C. Eiden, O. Mathieu, P. Cathala, C. Diot, M. Delage, E. Baccino and H. PeyrièreLa Revue de Médecine Légale 7 (4) 137 (2016)
https://doi.org/10.1016/j.medleg.2016.08.003
Comment identifier un signal en addictovigilance ?
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie DaveluyTherapies 70 (2) 113 (2015)
https://doi.org/10.2515/therapie/2015009
Signal Identification in Addictovigilance: the Functioning of the French System
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, Françoise Haramburu and Amélie DaveluyTherapies 70 (2) 123 (2015)
https://doi.org/10.2515/therapie/2015011
Utilisation des génériques de la buprénorphine haut dosage (BHD) : évaluation qualitative
Yohan El-Haïk, Elisabeth Frauger, Nicolas Tanti-Hardouin, Joëlle Micallef and Xavier ThirionTherapies 69 (3) 239 (2014)
https://doi.org/10.2515/therapie/2014032